Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia

Inclusion Criteria: 1. Adult aged 19 or older at the time of the baseline visit. 2. A patient with hypertension and dyslipidemia who is scheduled to administer olomax tablet according to investigator's medical judgement. * Patients who were previously taking more than two tablets of a single drug, low-density lipoprotein-cholesterol (LDL-C) * Patients who were previously only taking blood pressure-lowering drugs and did not take LDL-C-lowering drugs, but who need to take additional LDL-C-lowering drugs at the discretion of the researcher * Patients who were previously taking LDL-C lowering agents and did not take blood pressure lowering agents, but who need to take additional blood pressure lowering agents according to the researcher's judgment * Patients who have not previously taken both a blood pressure drop and an LDL-C drop but need additional simultaneous use at the discretion of the researcher 3. A person who can understand the information provided to him/her and may voluntarily sign a written consent form Exclusion Criteria: 1. A person who falls under the prohibition of administration according to the permission for olomax tablet 2. A person who has a history of administering olomax tablets before participating in this study 3. In addition to the above, a person that the investigator thinks he/she is not suitable for participating in this observation study;